Ca2+/Calmodulin induces translocation of membrane-associated TSC2 to the nucleus where it suppresses CYP24A1 expression

Biosci Biotechnol Biochem. 2022 Dec 21;87(1):45-53. doi: 10.1093/bbb/zbac174.

Abstract

Tuberous sclerosis complex 2 (TSC2) is a tumor-suppressor protein. A loss of TSC2 function induces hyperactivation of mechanistic target of rapamycin (mTOR). The C-terminal region of TSC2 contains a calmodulin (CaM) binding region and the CaM-TSC2 interaction contributes to proper mTOR activity. However, other downstream signaling pathways/effectors activated by the CaM-TSC2 complex have not been fully elucidated. In this study, we found that activation of Ca2+/CaM signaling resulted in the translocation of membrane-associated TSC2 to the nucleus and suppressed the transcriptional activity of the vitamin D receptor (VDR). TSC2 was released from the membrane in an activated CaM-dependent state in rat brain and HeLa cells. It subsequently formed a transcriptional complex to partially suppress the transcription of CYP24A1, a well-known VDR target gene. These data suggest, in part, that TSC2 attenuates VDR-associated transcriptional regulation via Ca2+/CaM signaling.

Keywords: CYP24A1; CaM; TSC2; translocation; vitamin D metabolism.

MeSH terms

  • Animals
  • Calcium / metabolism
  • Calmodulin* / metabolism
  • HeLa Cells
  • Humans
  • Rats
  • TOR Serine-Threonine Kinases / metabolism
  • Tuberous Sclerosis Complex 2 Protein / metabolism
  • Tuberous Sclerosis*
  • Vitamin D3 24-Hydroxylase / metabolism

Substances

  • Calmodulin
  • Vitamin D3 24-Hydroxylase
  • Calcium
  • Tuberous Sclerosis Complex 2 Protein
  • TOR Serine-Threonine Kinases
  • CYP24A1 protein, human

Supplementary concepts

  • Tuberous Sclerosis 2